Stock 3320 CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders China Resources Pharmaceutical Group Limited

Equities

3320

HK0000311099

Delayed Hong Kong S.E.
Other stock markets
 03:33:20 2024-04-30 am EDT 		5-day change 1st Jan Change
5.07 HKD -0.39% Intraday chart for China Resources Pharmaceutical Group Limited +6.51% -1.17%
Apr. 24 China Resources Pharmaceutical Group Limited Announces Change of Company Secretary CI
Apr. 18 China Resources Pharma Unit Issues 3 Billion Yuan Bonds MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China Resources Pharmaceutical Group Limited Announces Change of Company Secretary
CI
China Resources Pharmaceutical Group Limited Announces Management Changes, Effective on 27 December 2023
CI
China Resources Pharmaceutical Group Limited Announces Board and Executive Changes
CI
China Resources Pharmaceutical Group Limited Announces Appointment of Non-Executive Director
CI
China Resources Pharmaceutical Group Limited Announces Retirement of Mr. Tan Ying as Non-Executive Director
CI
China Resources Pharmaceutical Group Limited Announces CEO Changes
CI
China Resources Pharmaceutical Group Limited Announces Executive Changes
CI
China Resources Pharma CEO Takes on Dual Role Following Chairman's Exit
MT
China Resources Pharmaceutical Group Limited Announces Board Changes
CI
China Resources Pharmaceutical Group Limited Announces Board Changes
CI
China Resources Pharmaceutical Group Limited Announces Changes of Non-Executive Directors and Member of the Audit Committee
CI
China Resources Pharmaceutical Group Limited Announces Management Changes
CI
China Resources Pharmaceutical Group Limited Announces Management Changes
CI
China Resources Pharmaceutical Group Limited Announces Management Change
CI
China Resources Pharmaceutical Group Limited Announces the Resignation of FU Yuning as Chairman of the Board, Non-Executive Director and Chairman of the Nomination Committee
CI
China Resources Pharmaceutical Group Limited Announces Resignation of SONG Qing as Executive Director, President and Member of Executive Committee
CI
China Resources Pharmaceutical Group Limited Announces Management Changes
CI
WANG Chenyang Not to Offer for Re-Election as Director of China Resources Pharmaceutical Group Limited
CI
China Resources Pharmaceutical : APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR, CHAIRMAN OF AUDIT COMMITTEE, AND MEMBER OF REMUNERATION COMMITTEE, NOMINATION COMMITTEE AND CORPORATE GOVERNANCE COMMITTEE
PU
China Resources Pharmaceutical Group Limited Appoints Mdm. Shing Mo Han Yvonne as an Independent Non-Executive Director, Chairman of the Audit Committee and Member of the Remuneration Committee, Nomination Committee and Corporate Governance Committee
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 3320 Stock
  4. News China Resources Pharmaceutical Group Limited
  5. Insiders